Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding

Inclusion Criteria: * Peptic ulcer with high-risk stigmata of recent hemorrhage (Forrest class IA, IB, IIA and IIB) Exclusion Criteria: * Subjects who have a history of malignant tumor in upper gastro-intestinal site * Subjects with platelet and coagulation dysfunction (PLT \< 50E9/L, INR \> 2) * Subjects that have taken anticoagulant drugs or non-steroidal anti-inflammatory drugs within 72 hours after the treatment * Subjects with one or more bleeding sources * Subjects who are pregnant or breast-feeding * Subject who are allergic or have a hypersensitive reaction to Hydroxyethyl-cellulose or EGF * Subjects who have undergone endoscopically therapies within the last 7 days * Subjects who are considered not suitable for the study by significant disease * Subjects who are not able to comply with the study requirements * Subjects who are currently enrolled in another clinical study which can impact the study within 30 days of screening * Subjects who are considered not suitable for the study by the investigator